Background {#Sec1}
==========

Transcription factors (TFs) direct cell fate determination and differentiation through binding to a genomic network consisting of regulatory elements (REs) such as promoters and enhancers. By analyzing epigenetic modifications and transcriptional changes in TF knockouts, we have started to uncover the genomic networks and molecular mechanisms that direct brain development \[[@CR1]\]. In-depth understanding of the genetically encoded wiring of the brain is important as perturbation of transcription pathways is implicated in disorders such as autism and intellectual disability \[[@CR2]\]. Distantly acting REs have been identified based on conservation and activity \[[@CR3], [@CR4]\]. Their spatial activity and dynamic genomic contacts can be predicted using a combination of TF binding profiling, genome-wide 3D chromosome organization mapping and CRISPR/Cas9 editing \[[@CR5]--[@CR10]\].

Mouse genetic experiments have elucidated the functions of many TFs in the development of the subpallial telencephalon \[[@CR11], [@CR12]\]. These studies show that the HD protein NKX2--1 is required for regional specification of the MGE by repressing alternative identities, as well as promoting GABAergic and cholinergic cell fates via the induction of TFs such as LHX6 and LHX8 \[[@CR13]--[@CR17]\]. By integrating genomic data with mouse genetics, we confirmed the repressive function of NKX2--1, however its role in transcriptional activation remains unclear. Moreover, additional data suggests that genes genetically downstream of NKX2--1, such as LHX6 and LHX8, are responsible for the loss of gene expression observed in the *Nkx2--1*cKO \[[@CR18], [@CR19]\]. Altogether, the genetic program and molecular mechanisms responsible for promoting GABAergic and cholinergic neuron phenotypes, downstream of NKX2--1 remains largely unexplored.

To investigate the signaling pathways of MGE development downstream of NKX2--1, we extended our earlier analysis of the genomic network directing MGE development that is altered in the *Nkx2--1* mutant. First we evaluated all loci that showed an epigenetic change, independent of NKX2--1 binding. Via an epigenomic analysis of the NKX2--1 mutant MGE we characterized a large set REs that are implicated in mediating transcriptional repression and activation. Using a combination of genomics, de novo *motif* analysis, CRISPR engineering and primary culture assays we characterize REs and TFs central to patterning of the subpallial telencephalon and promoting MGE characteristics. Gene ontology (GO) analysis showed an enriched association of REs activating transcription (aREs) with E-box binding basic-Helix-Loop-Helix (bHLH) TFs. Using CRISPR engineering we deleted *hs623*, an intronic aRE of the *Tcf12* gene which encodes a bHLH TF. Deletion of *hs623* reduced *Tcf12* expression in the MGE. De novo motif analysis combined with TF motif mutations, showed that OCT/POU and SOX motifs are required for *hs623*'s ability to promote transcription in the MGE.

Methods {#Sec2}
=======

Mice {#Sec3}
----

The *Nkx2--1*cKO was earlier described in Sandberg et al. 2016 \[[@CR18]\] and generated using mice strains previously reported: *Nkx2--1f/f* \[[@CR20]\], *Olig2-tva*-Cre \[[@CR21]\] and *AI14* Cre-reporter \[[@CR22]\]. All experiments with animals complied with federal and institutional guidelines and were reviewed and approved by the UCSF Institutional Animal Care and Use Committee.

Generation of *hs623* deletion {#Sec4}
------------------------------

The *hs623*^*Tm1*^ allele was generated by CRISPR-mediated genome editing, using established methods \[[@CR23]\]. Guide RNAs sgRNA-*hs623*--1, 5′-GTTTAGTTTTGCTCATACCA(TGG)-3′ and sgRNA-*hs623*--2, 5′-ATGGTTTCTGTGATCGTAAT(TGG)-3′ (protospacer-adjacent motif \[PAM\] sequence indicated in parentheses) were transcribed in vitro using the MEGAshortscript T7 kit (Life Technologies, AM1354) and subsequently purified using the MEGAclear kit (Life Technologies, AM1908). The two guide RNAs were designed to delete a 737 bp intronic region within *Tcf12* \[mm9; chr9:71822812--71823548\]. The purified sgRNAs were co-injected into the cytoplasm of fertilized mouse oocytes with in vitro transcribed Cas9 mRNA using standard transgenic procedures as previously described \[[@CR24]\]. F0 transgenic founders were identified by PCR screening using *hs623*-KO-F, 5′- GTCATTGTTGCTGTTGGCCT -3′ and *hs623*-KO-R, 5′- CCACCTCACACTAGATTAAGATACA -3′ to identify the *hs623* null alleles (KO = 250 bp, WT = 1008 bp) and *hs623*-WT-F, 5'-GTGGCTGATGATGTGCTCTGA -3′ and *hs623*-WT-R, 5'-CTCCATCAGGTTCTTGCCCC-3′ to identify the *hs623*-WT allele (462 bp). Four independent F0 founders were each outcrossed to wild type mice, and F1 offspring were used for subsequent *hs623*^*Tm1*^ intercrosses to generate *hs623*-null mice. The hs623 mutant strain (CD1-*Tcf12*^*em1Jlr*^/Mmucd) is available at MMRC ([www.mmrrc.org/](http://www.mmrrc.org/)) with the number RRID: MMRRC_044027-UCD.

Histology {#Sec5}
---------

Immunofluorescence was performed on 16 μm cryosection as previously described \[[@CR25]\]. In situ hybridization was performed as previously described \[[@CR26]\]. The following primers were used generate the templates used for the in situ probes: Tcf12_F, TCTCGAATGGAAGACCGC; Tcf12_R, CTCCCTCCTGCCAGGTTT.

Dissection of embryos {#Sec6}
---------------------

RT-qPCR and primary culture experiments were performed on E13.5 micro-dissected MGE. All MGE dissections were performed as follows; the dorsal boundary was defined by the sulcus separating lateral ganglionic eminence (LGE) and MGE. The caudal end of the sulcus defined the caudal boundary. Septum was removed.

Gene expression analysis in *hs623*KO {#Sec7}
-------------------------------------

To assay differential gene expression in the *hs623*KO RNA was purified using RNEasy Mini (Qiagen) and cDNA was generated using Superscript III® First-Strand Synthesis System for RT-PCR (Invitrogen). RT-qPCR analysis was performed on a 7900HT Fast Real-Time PCR System (Applied Biosystems) using SYBR GreenER qPCR SuperMix (Invitrogen, Cat. No. 11760--100). Unpaired t-test was used to test significance in gene expression between *hs623*WT and *hs623*KO using SDHA as internal control \[[@CR27], [@CR28]\].

Sequences of RT-qPCR primers used:SDHA-F, GCTCCTGCCTCTGTGGTTGASDHA-R, AGCAACACCGATGAGCCTGMns1_ctrl_1F, CTGCTGCTCCGGAAGACGMns1_ctrl_1R, TTTTGGTCGCCATCTCGGTTMyzap_ctrl_2F, TCGAAAGGAAAGATCAGCCTCCMyzap_ctrl_2R, TCTGATCTTCGCACCACACCZfp280d_ctrl_1F, CCCCAGCTCTCATTCAAGAGGZfp280d_ctrl_1R, TTCAGGCAGCGTTGACTTGTTCF12_v1/2-F2, GCTTGTCCCCAACACCTTTCTCF12_v1/2-R2, TGACAGCCTGAGAGTCCAGATCF12_v1/3-F4, TACCAGTCAGTGGCCCAGAGTCF12_v1/3-R4, AATGCTCGTGAAGTTGCTGCTCF12_v1/3-F5, TCCCTGGAATGGGCAACAATTCF12_v1/3-R5, TCACGGTTGAAATCGTCAGA

Site-directed mutagenesis of TF binding motifs in *hs623* {#Sec8}
---------------------------------------------------------

To study the requirement TF motifs for *hs623* activity LHX6, SOX and octamers were mutated in pCR-Blunt II-TOPO, sequence verified and sub-cloned into a pGL4.23-Luciferase reporter with a minimal β-globin-promoter using BglII and XhoI \[[@CR18]\]. Following primers were used to generate the different *hs623* luciferase reporters:*hs623*-mut-site\#1-R, cgttgctgacaaggctgttttttacagaaattgatgctgagttc*hs623*-mut-site\#1-F, agccttgtcagcaacgtgattattcaaac*hs623*-mut-site\#2-F, gatgtgctctgatatgaaaaaagtcattaggtagaatgaatag*hs623*-mut-site\#3-F, gatgtgctctgatatgtaattagaaaaaaggtagaatgaatag*hs623*-mut-site\#2 and 3-F, gatgtgctctgatatgaaaaaagaaaaaaggtagaatgaatag*hs623*-mut-site\#2 and/or 3-R, atatcagagcacatcatcagccacattc*hs623*-mut-site\#4-F, gattattcaaacaactcttttttttgttaatgagg*hs623*-mut-site\#4-R, gagttgtttgaataatcacgttgctgac*hs623*-mut-site\#5-F, ctcatgcaaatgaaaaagaggccttatttgc*hs623*-mut-site\#5-R, atttgcatgagttgtttgaataatc*hs623*-mut-site\#4 and 5-F, caaacaactcttttttttgaaaaagaggccttatttgc*hs623*-mut-site\#4 and 5-R, use "*hs623*-mut-site\#4-R" for PCR*hs623*-mut-site\#6-F, gttaatgaggccttaaaaaaatatttattttttcc*hs623*-mut-site\#6-R, ggcctcattaacatttgcatgagttgtttg*hs623*-mut-site\#4 and 6-F, caactcttttttttgttaatgaggccttaaaaaaatatttattttttcc*hs623*-mut-site\#4 and 6-R, cattaacaaaaaaaagagttgtttgaataatcac*hs623*-mut-site\#4,5 and 6-F, caactcttttttttgaaaaagaggccttaaaaaaatatttattttttcc*hs623*-mut-site\#4, 5 and 6-R, ggcctctttttcaaaaaaaagagttgtttgaataatc*hs623*-mut-site\#7-F, gcaacgtgattattcccccccctcatgcaaatg*hs623*-mut-site\#7-R, gaataatcacgttgctgacaagg*hs623*-mut-site\#4 and 7-F, gtgattattcccccccctcttttttttgttaatgagg*hs623*-mut-site\#4 and 7-R, use *hs623*-mut-site\#7-R

Analysis of *hs623* activity in MGE primary MGE cultures {#Sec9}
--------------------------------------------------------

MGE tissue was dissected from E13.5 embryos, triturated and plated onto 24-well plates (1 embryo/2wells). Primary cultures were transfected with a total of 500 ng DNA using Lipofectamin 2000 (Thermo Fisher) and cultured in Neurobasal Medium (Thermo Fisher) supplemented with 0.5% Glucose, GlutaMAX (Thermo Fisher Scientific) and B27 (Thermo Fisher Scientific). Luciferase assays were performed 48 h after transfection using Dual Luciferase Reporter Assay System (Promega). Unpaired t-test was used to test significance between the variants of *hs623*.

ChIP-Seq computational analysis {#Sec10}
-------------------------------

Differential ChIP-seq analysis was performed as described in Sandberg et al. 2016 \[[@CR18]\]. After differential H3K4me1, H3K27ac and H3K27me3 analysis we merged overlapping sites. Only merged sites that were enriched in H3K4me1 relative to the input datasets and for which the difference in enrichment between *Nkx2--1* WT and cKO was not significant (for at least one of the sites among the merged sites) were further considered. Of those, merged sites overlapping with blacklisted genomic regions (<http://mitra.stanford.edu/kundaje/akundaje/release/blacklists/mm9-mouse/mm9-blacklist.bed.gz>) and RepeatMasker annotation (http://hgdownload.cse.ucsc.edu/goldenPath/mm9/database/chr\*\_rmsk.txt.gz) as well as those exceeding 5000 bp were excluded. We defined aREs based on the following two criteria; 1) more H3K27ac (WT) and no increase in H3K27me3 (WT), H3K27ac (*Nkx2--1*cKO) and H3K4me1 (*Nkx2--1*cKO), 2) more H3K27me3 (*Nkx2--1*cKO) and no increase in H3K27ac (*Nkx2--1*cKO), H3K4me1 (*Nkx2--1*cKO) and H3K27me3 (WT). We defined rREs based on the following two criteria; 1) more H3K27ac (*Nkx2--1cKO)* and no increase in H3K27me3 (*Nkx2--1*cKO*)*, H3K27ac (WT) and H3K4me1 (WT), 2) more H3K27me3 (*WT)* and no increase in H3K27ac (WT), H3K4me1 (*WT)* and H3K27me3 (*Nkx2--1*cKO*)*.

In vivo analysis of aREs and rREs {#Sec11}
---------------------------------

To assess the in vivo activity of aREs and rREs we used the data published in the VISTA Enhancer Browser (<https://enhancer.lbl.gov/>) \[[@CR7]\]. All aREs and rREs, overlapping with regions tested in the VISTA Enhancer Browser were scored based on their in vivo activity in cortex, MGE and LGE. For the MGE active elements, we also scored their activity in the ventricular zone (VZ), SVZ and MZ.

De novo motif analysis {#Sec12}
----------------------

Motif analysis was performed using RSAT \[[@CR29]\], identifying overrepresentation and positional bias of words (6 to 7 nucleotides) in the aREs and rREs using an automated Markov model adapted after the analyzed sequence length. Differential analysis of aREs (rREs as control sequence) and rREs (aREs as control sequence) was also performed to identify overrepresented words in the peak sequence.

Results {#Sec13}
=======

Identification of the genomic regulatory network directing MGE identity {#Sec14}
-----------------------------------------------------------------------

We have previously shown that the combined binding of NKX2--1 and LHX6 is a predictive indicator of REs that mediate transcriptional activation in the subventricular (SVZ) and mantle zone (MZ) of the MGE in the developing subpallial telencephalon \[[@CR18]\]. There is evidence that NKX2--1 generally acts as a repressor in MGE progenitors (in the ventricular zone \[VZ\]), whereas LHX6, and potentially other TFs and signaling pathways, some of which are genetically downstream of NKX2--1, are important for activating transcription in the SVZ and MZ of the MGE \[[@CR18], [@CR30]\]. By studying aREs, we aimed to further explore the molecular mechanisms underlying the transcriptional network directing differentiation of the secondary progenitors in the SVZ. One important difference between this study and our earlier study \[[@CR18]\] is that here we look at all aREs and rREs, independent of NKX2--1 binding.

First we identified aREs and rREs by assessing the genome-wide changes of the two histone marks H3K27ac and H3K27me3 at H3K4me1 positive REs comparing the WT and *Nkx2--1*cKO MGE \[[@CR18]\]. We defined aREs based on the following two criteria; 1) reduced H3K27ac and, 2) increased H3K27me3 in the *Nkx2--1*cKO. We defined rREs based on the following two criteria; 1) increased H3K27ac and, 2) reduced H3K27me3 in the *Nkx2--1*cKO (see Methods).

Based on these criteria we identified 4782 aREs and 6391 rREs in the *Nkx2--1*cKO. See Additional file [1](#MOESM1){ref-type="media"} for a complete list of aREs and rREs. To analyze the in vivo activity patterns of the aREs and rREs we examined transgenic enhancer activity patterns of E11.5 forebrain enhancer activity patterns available in the VISTA database (see VISTA data base; <https://enhancer.lbl.gov>/) \[[@CR7]\]. The activities of rREs were highest in cortex (62% \[13 of 21\]) and LGE and dorsal MGE (52% \[11 of 21\]) and lowest in the ventral MGE (24% \[5 of 21\])(Fig. [1a](#Fig1){ref-type="fig"} and [b](#Fig1){ref-type="fig"} \[hs848, hs1172 and hs1187\]). In contrast, aREs have the highest activities in the MGE (53% \[17 of 32\]) when compared to their activities in the LGE (50% \[16 of 32\]) and cortex (41% \[13 of 32\]) (Fig. [1a](#Fig1){ref-type="fig"} and [b](#Fig1){ref-type="fig"} \[hs676, hs957 and hs1041\]). We also found a higher activity of MGE positive aREs in the SVZ (71% \[12 of 17\]) and MZ (94% \[16 of 17\]) compared to the VZ (18% \[3 of 17\]), consistent with our previous results for NKX2--1 bound aREs and rREs (Fig. [1b](#Fig1){ref-type="fig"} and [c](#Fig1){ref-type="fig"}) \[[@CR18]\]. See Additional file [1](#MOESM1){ref-type="media"} for a full list of aREs and rREs VISTA transgenics.Fig. 1Characterization of aREs and rREs in E13.5 MGE. **a** Proportion of aREs and rREs active in MGE, LGE and cortex. **b** Sections of transgenic embryos (from the VISTA browser) showing in vivo activity of rREs (hs848, hs1172 and hs1187) and aREs (hs676, hs957 and hs1041) at E11.5. **c** VZ, SVZ, and MZ activity of aREs in the MGE at E11.5. Chi-square test was used to test significance between the groups: \**p* \< 0.05. **d** and **e** Manually curated list of de novo motifs and potential TF recognizing the motifs in rREs and aREs. **f** Enriched gene ontology annotations of putative aRE target genes

To identify TFs motifs enriched in the aRE and rREs we performed a de novo motif discovery using RSAT \[[@CR29]\]. This analysis showed a number of motifs enriched in both aREs and rREs such as SOX motifs, homedomain binding motifs (HOX and POU6f2) and motifs recognized by zinc finger TFs (e.g. SP1 and ZNF384) (Fig. [1d](#Fig1){ref-type="fig"} and [e](#Fig1){ref-type="fig"}). Additional analysis identifying motifs differentially enriched between aREs and rREs showed that aREs have a high frequency of E-boxes (Fig. [1e](#Fig1){ref-type="fig"}). Interestingly, we found that rREs are enriched in motifs consistent with the binding site of the TF MEIS2 (Fig. [1d](#Fig1){ref-type="fig"}). The *Meis2* gene is repressed by NKX2--1, and in turn, its RNA is strongly up-regulated in the MGE of the *Nkx2--1*cKO \[[@CR18]\]. These data suggest that *Meis2* is central to activating a genomic network promoting LGE and caudal ganglionic eminence (CGE) characters (through rREs) in the *Nkx2--1*cKO MGE.

We then examined enrichment of annotation terms among the aREs and rREs candidate target genes using GREAT \[[@CR31]\]. Top-ranked GO terms for rREs target genes were associated with WNT signaling (beta-catenin binding and PDZ domain binding), transcriptional regulation (such as RNA polymerase II transcription co-activator activity), and enhancer sequence-specific DNA binding (Fig. [1f](#Fig1){ref-type="fig"}). Looking specifically at the associated genes for the rREs containing MEIS2 binding motifs we found several genes (*Isl1, Ebf1, Tle4, Zfp503, Efnb1* and *Efnb2*) with higher expression in the LGE and CGE than the MGE. These findings support the hypothesis that MEIS2 directs LGE and CGE identities. The top-ranked GO terms for aREs target genes were associated with phosphatase activity, E-box binding proteins, L-glutamate transmembrane transporter activity and transmembrane-ephrin receptor activity \[[@CR31]\] (Fig. [1f](#Fig1){ref-type="fig"}). Two E-box binding TFs, *Tcf4* and *Tcf12*, which are in the region of a large number of aREs, have reduced MGE SVZ and MZ expression in the *Nkx2--1*cKO \[[@CR18]\]. In combination with the high frequency of E-boxes in aREs, our data suggests that *Tcf4* and *Tcf12* are components of the genomic network regulating gene expression in secondary progenitors of the MGE that are genetically downstream of NKX2--1.

In vivo characterization of *hs623* in the MGE of the forebrain {#Sec15}
---------------------------------------------------------------

To learn more about the *Tcf12* expression and the transcriptional pathways integrated in the aRE network downstream of NKX2--1, we examined aRE *hs623*, a highly evolutionarily conserved 914 base pair (bp) sequence that is in an intron of the *Tcf12* locus (Fig. [2a](#Fig2){ref-type="fig"} and [b](#Fig2){ref-type="fig"}). A previous transgenic study show that *hs623* drives *LacZ* expression at E11.5 \[[@CR32]\]. The *hs623* transgene is active in the forebrain, hindbrain and the spinal cord (Fig. [2c-e](#Fig2){ref-type="fig"}, Additional file [2](#MOESM2){ref-type="media"}). A coronal section through the telencephalon shows that *hs623* activity is restricted to the SVZ and MZ of the MGE, and perhaps labels cell tangentially migrating into the LGE (Fig. [2e](#Fig2){ref-type="fig"}). This pattern of activity is supported by histone ChIP-seq analysis of the MGE showing that this locus has histone modifications that are characteristic of active enhancer elements (Fig. [2a](#Fig2){ref-type="fig"} \[H3K4me1+ and H3K27ac+\] and 2B). Of note, ChIP-seq analysis of the MGE *Nkx2--1*cKO shows reduced H3K27ac, providing evidence that the activity of the locus is dependent on the activity of the NKX2--1 and/or its target TFs, as reported earlier (Fig. [2b](#Fig2){ref-type="fig"}) \[[@CR18]\].Fig. 2Deletion of *cis*-regulatory element *hs623* in vivo. **a** Genomic region of the *Tcf12* locus with the ChIP-seq datasets and genomic features shown; NKX2--1 ChIP-seq, LHX6 ChIP-seq, H3K4me3, H3K4me1, H3K27ac, H3K27me3, UCSC genes and mammalian conservation. Histone 3 modifications in MGE at E13.5. *Hs623* region framed and highlighted in blue. **b** Higher resolution view of the *hs623* region with the same ChIP-seq datasets as in Fig. 2a. Called NKX2--1 & LHX6 binding region, VISTA regions, deleted *hs623* region (yellow) and NKX2--1, LHX6 and OCT consensus motifs labeled at the top of the browser. **c**-**g** VISTA database transgenic embryos showing in vivo activity of *hs623* and *hs357* at E11.5. **h** Schematic description of the generated *hs623* deletions (5 founders). The distribution of LHX6 consensus motifs in *hs623* are indicated. Founder 2458 was used for the analysis presented in this paper

Motif logic direct region specific transcriptional activity {#Sec16}
-----------------------------------------------------------

*Hs623* is flanked by two highly conserved regions and the activity of one of the regions (*hs357)* has been tested in vivo \[[@CR32]\]. Similar to *hs623, hs357* is active in the spinal cord, but unlike *hs623* it is active in the pretectum and it lacks activity in the telencephalon, including the MGE (Fig. [2f](#Fig2){ref-type="fig"} and [g](#Fig2){ref-type="fig"}). Therefore, despite the close proximity of *hs623* and *hs357*, they show differences in regional activity, suggesting that their regional activities are more likely due to differences in their primary nucleic acid sequence rather then their genomic location. Consistent with the lack of MGE activity, *hs357* has two NKX2--1 consensus motifs and no LHX6 consensus motifs (Fig. [2b](#Fig2){ref-type="fig"}). On the other hand, *hs623* has four LHX6 consensus motifs, which could explain its activity in the MGE (Fig. [2h](#Fig2){ref-type="fig"}). Even though *hs623* has NKX2--1 binding, it contains no NKX2--1 consensus motifs. However, the sequences flanking *hs623* do include three NKX2--1 consensus motifs, two within *hs357* (Fig. [2b](#Fig2){ref-type="fig"}). In agreement with these observations, we detect NKX2--1 binding covering a wide region that incudes both *hs623* and *hs357*.

CRISPR/Cas9 mediated deletion of *hs623* in vivo {#Sec17}
------------------------------------------------

To functionally test the requirement of *hs623* in vivo, we deleted *hs623* using CRISPR/Cas9 (see VISTA database; <http://enhancer.lbl.gov>). A pair of sgRNAs was designed to delete the 734 bp core sequence of *hs623*, which has NKX2--1 and LHX6 binding (Fig. [2b](#Fig2){ref-type="fig"} and [h](#Fig2){ref-type="fig"}). Microinjection of sgRNAs and Cas9 generated a total of 22 pups. 23% (5 of 22) of the pups carried the desired *hs623* deletions and the induced DNA breaks were distributed within 20 bp of the predicted cutting site (5′ and 3′ of *hs623*, Fig. [2h](#Fig2){ref-type="fig"}, Additional file [3](#MOESM3){ref-type="media"}). To minimize potential off target effects we outcrossed the F0 transgenic founders to wild-type CD1 mice. Four of five founders were fertile and generated a F1 generation; these animals were intercrossed to generate homozygous F2 *hs623KO* animals. *Hs623KOs* in the F2 generation were produced at Mendelian Ratios showing that the enhancer deletion was viable (10\[WT\]:19\[HET\]:7\[KO\], *n* = 3 litters; χ^2^ = 0.611; df = 2; *p* = 0.7367). Due to the overall similarity of the four fertile founders we decided to focus the following analysis on one of the founders (F0: 2458, Fig. [2h](#Fig2){ref-type="fig"}).

Deletion of *hs623* reduces *Tcf12* mRNA levels in the SVZ of MGE {#Sec18}
-----------------------------------------------------------------

*Hs623* is a *Tcf12* intragenic RE that in transgenic assays activates transcription in the SVZ of the MGE (Fig. [2c-e](#Fig2){ref-type="fig"}). As noted above, its activity is partly dependent on NKX2--1 activity and *Tcf12* transcription is specifically reduced in the SVZ of the MGE in the *Nkx2--1*cKO (Fig. [2b](#Fig2){ref-type="fig"}) \[[@CR18]\]. Together, these data suggest that *hs623* could be a RE activating *Tcf12* transcription in the MGE. To test this hypothesis, we performed RTqPCR on the MGE from *hs623WTs* and *hs623KOs* at E13.5. Primers were designed to target all known mouse protein-coding and non-protein-coding genes in the NCBI RNA reference sequences collection that are found 450 kb up- and downstream of *hs623* (Fig. [3a](#Fig3){ref-type="fig"}). From the RTqPCR we found no significant difference in the expression of the following genes in this region: *Myzap*, *Cgln1*, *Zfp280d* and *Mns1* (Fig. [3b](#Fig3){ref-type="fig"}). *Tcf12* RNAs include a variety of splice variants. Because of this we designed three separate primer pairs to specifically interrogate the different splice variants of *Tcf12* (Fig. [3a](#Fig3){ref-type="fig"}). We found a reduction in the expression of the short isoforms of *Tcf12* isoform 3 and 4 (Fig. [3b](#Fig3){ref-type="fig"}, see *Tcf12*\_v1/3--4 and *Tcf12*\_v1/3--5). Notably, we did not find any difference in the expression levels of the longer isoforms 1 and 2 of *Tcf12* (Fig. [3b](#Fig3){ref-type="fig"}, see *Tcf12*\_v1/2--2). Together, these results show that *Tcf12* transcription in the MGE is enhanced by *hs623*.Fig. 3Reduced *Tcf12* expression in the *hs623*KO. **a** *Tcf12* locus with neighboring genes. **b** qPCR analysis of *Mns1*, *Myzap*, *Cgln1*, *Zfp280d*, *Tcf12* isoforms 1 and 3 (*Tcf12*\_v1/3--4), *Tcf12* isoforms 3 and 4 (*Tcf12*\_v1/3--5), *Tcf12* variant 1 and 2 (*Tcf12*\_v1/2--2) on WT and *hs623*KO MGE at E13.5. The colors used in the table correlate to the specific target regions indicated in Fig. 3a. **c** and **d** In situ hybridization analysis of *Tcf12* in WT (**c**) and *hs623*KO (**d**) basal ganglia at E13.5. Unpaired t-test was used to test significance between the groups: \**p* \< 0.05

To obtain spatial information about the reduction of *Tcf12* within the MGE we compared the distribution of *Tcf12* RNA between WT and *hs623KO* telencephalon at E13.5 using in situ RNA hybridization. Normally, *Tcf12* is broadly expressed in the VZ in the pallium and subpallium. In the ganglionic eminences *Tcf12* is also expressed in the SVZ and MZ, with a markedly higher expression in the MGE compared to the LGE. On the other hand, in the *hs623KO* we observed a reduction of *Tcf12* expression that appeared to be specific to the SVZ and MZ of the MGE (Fig. [3c](#Fig3){ref-type="fig"} and [d](#Fig3){ref-type="fig"}). This result is consistent with the spatial activity of *hs623*, which is restricted to the SVZ of the MGE.

Combined activity of POU and SOX TFs are required to maintain gene expression downstream of NKX2--1 in the MGE {#Sec19}
--------------------------------------------------------------------------------------------------------------

To test the functional requirement of the LHX6 motifs in *hs623* we made site directed mutations that removed all four LHX6 motifs (*hs623*ΔLHX). In MGE primary cultures the activity of *hs623*ΔLHX was reduced by half when compared to the non-mutated *hs623* (*hs623*WT, Fig. [4a](#Fig4){ref-type="fig"} and [b](#Fig4){ref-type="fig"}). Together, these experiments provide evidence that *hs623* activity, in part, depends on LHX6 and LHX8 and that there are additional TFs and signaling pathways required for the activity of *hs623*. Our earlier motif analysis of aREs discovered an enrichment of additional motifs such as HD-binding motifs (POU6f2 and HOX), SOX motifs and E-boxes (Fig. [1e](#Fig1){ref-type="fig"}). To identify additional TF pathways responsible for the activity of *hs623* we looked at the other identified de novo motifs within *hs623* (Fig. [1d](#Fig1){ref-type="fig"}). Located in the center of *hs623* we found two octamers (bound by POU TFs), of which one is adjacent to a SOX motif. Octamers are known to pair with SOX motifs to form central functional units regulating development in various cell types \[[@CR33]--[@CR35]\]. Initially, we analyzed the activity of the two individual octamers by generating single mutations of the two motifs (Fig. [4a](#Fig4){ref-type="fig"}, *hs623*ΔOCT1 and *hs623*ΔOCT2). Mutating octamer 1 (*hs623ΔOCT1*) caused a significant reduction of *hs623* activity in MGE primary cultures, whereas mutating octamer 2 (*hs623ΔOCT2*) had no significant effect on *hs623* activity (Fig. [4b](#Fig4){ref-type="fig"}). Octamer 2 is located 3 bp from a SOX consensus motif (Fig. [4a](#Fig4){ref-type="fig"}). To assess the requirement of this combined motif for *hs623* activity, we generated a compound mutant with a combined mutation of octamer 2 and the paired SOX motif (*hs623*ΔOCT2 + SOX). *Hs623*ΔOCT2 + SOX showed a significantly reduced activity when compared to *hs623*WT as well as, the two individual single mutants, *hs623*ΔOCT2 and *hs623*ΔSOX (Fig. [4b](#Fig4){ref-type="fig"}).Fig. 4OCT and SOX motifs required for *hs623* activity in primary MGE cultures. **a** Schematic of *hs623* with LHX6, OCT and SOX motifs. **b** Luciferase reporter assay showing a reduced activity of *hs623* when LHX6, OCT and SOX motifs in *hs623* are mutated. Data are represented as mean ± SEM. Unpaired t-test was used to test significance between the groups: \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001, \*\*\*\**p* \< 0.0001

Altogether, our experiments show that *Tcf12* expression in the SVZ of the MGE is mediated, at least in part, through *hs623*, a RE that is strongly dependent on its OCT and SOX motifs and partially dependent on its LHX6 motifs. We have previously shown that gene expression in the SVZ of the MGE (including *Tcf12*) largely depends on NKX2--1 activity \[[@CR18]\]. Existing mechanistic data show that NKX2--1 acts as a transcriptional repressor. Therefore, our findings suggest that the loss of *Tcf12* expression in the SVZ of the MGE *Nkx2--1c*KO is not due to the direct regulation of *Tcf12* by NKX2--1, but is a secondary effect due to changes in expression and activity of LHX6, LHX8, OCT and SOX TFs.

Discussion {#Sec20}
==========

Technical advancements in genome wide sequencing, chromosome capture and CRISPR/Cas9 technologies are increasing our understanding of genome organization. These data, combined with data showing RE activities in vivo (<https://enhancer.lbl.gov/>), TF binding and other epigenetic genomic data, and spatial gene expression data (<http://www.brain-map.org/>, <http://www.eurexpress.org/ee/intro.html>), are enabling the field to begin elucidating the genomic networks and the molecular mechanisms that direct brain development. Herein we have used many of these approaches to analyze gene expression in the developing mouse MGE. In the context of the *Nkx2--1*cKO mouse, our analysis of differential (WT vs. cKO) histone ChIP-seq data, and de novo sequence motif analysis, has provided evidence for additional TFs, REs, and signaling pathways that direct MGE development.

In this study, we showed that *Tcf12* expression in the SVZ of the MGE is mediated via *hs623*, an aRE bound by NKX2--1. The activity of *hs623* and the expression of *Tcf12* depend on NKX2--1 activity, suggesting that NKX2--1 promotes *Tcf12* expression in this context. We find no direct evidence showing that NKX2--1 activates *Tcf12* transcription via *hs623*. On the other hand, we show that LHX6, OCT and SOX motives are central to *hs623* activity. In fact, *hs623* lacks NKX2--1 consensus motifs and its interaction with *hs623* can possibly be explained through binding to three flanking regions. Other alternative explanations are that NKX2--1 regulates *hs623* through either uncharacterized NKX2--1 motifs or through indirect binding to transcriptional complexes that bind *hs623*.

We have earlier demonstrated that NKX2--1 represses transcription in the MGE, similar to other NKX HD TFs that specify ventral parts of the developing neural tube \[[@CR36], [@CR37]\]. Even at aREs, identified in the *Nkx2--1*cKO MGE, the NKX2--1 motifs mediate transcriptional repression, as exemplified by the intragenic *Tgfb3* RE in Sandberg et al. 2016 \[[@CR18]\]. On the other hand, in the case of both the *Tgfb3* RE and *hs623*, LHX6 motifs promote enhancer activity. If NKX2--1 only represses transcription, it is unclear how loci such as LHX6 and LHX8 fail to be activated in the *Nkx2--1* mutants \[[@CR16]--[@CR18]\]. Furthermore it is unclear why NKX2--1 also binds loci that have reduced activity in the *Nkx2--1*cKO. These results suggest that, in some contexts, NKX2--1 may have an activating function. NKX2--1 binding to these loci might be required to keep them poised for subsequent activation by TFs and signaling pathways parallel and genetically downstream of NKX2--1, such as LHX, OCT, SOX and bHLH TFs. A similar model was presented in two studies looking at motor neuron development. In these cells, combinations of NEUROG2 (bHLH TF), LHX3, ISL-1, ONECUT1 and EBF direct the progression of the motor neuron fate through distinct sets of REs \[[@CR8], [@CR9]\]. Similar to these models, we find an enrichment of LHX6 binding and e-boxes at aREs, a group of REs with a preferential activity in the SVZ of the MGE. This combination of TF binding and motif enrichment is not seen at NKX2--1 bound rREs, that have a relatively low MGE activity. These data highlight similarities in the molecular mechanisms that direct MGE and motor neuron development over time. In addition to combinatorial activity with other TFs, the activity of NKX2--1 might be affected by changes to chromatin modifications at specific loci over time. Our experimental design lacks the temporal resolution to make these kinds of predictions. For the future, it would be interesting to know; 1) at what time point in the developing MGE (VZ, SVZ or MZ) are the various REs active, 2) and the temporal pattern of TF binding at these REs. This would give us important information that could help elucidate the activating and repressing mechanics through which NKX2--1, LHX6 and other TFs direct MGE development.

The seemingly dual activity of NKX2--1 in the MGE is similar to its double-edged characteristics in regulating cancer development and progression. In this context, NKX2--1 has a role as lineage-survival oncogene in developing lung cancer tumors. On the other hand, NKX2--1 expression is also associated with a favorable prognosis in affected patients, due to its capacity to attenuate the invasive capacity of carcinomas \[[@CR38]\]. Interestingly, this has been shown to be mediated through an abrogation of cellular response to TGFβ induced EMT, a signaling pathway that is directly repressed by NKX2--1 in the MGE \[[@CR18], [@CR39]\]. By identifying the mechanisms through which NKX2--1 operate in the subpallial telencephalon we might also learn more about its enigmatic role in tumor biology.

The activity of the RE *hs623* depends on two octamers, providing evidence that OCT TFs are central to MGE development. OCT TFs are important regulators of stem cell maintenance and the progression of neurogenesis. OCT4 is central for propagating undifferentiated embryonic stem cells and has the ability to induce pluripotent stem cells from embryonic and adult fibroblasts \[[@CR40], [@CR41]\]. On the contrary, BRN2, together with Ascl1 and Myt1l, can efficiently trans-differentiate embryonic and postnatal fibroblasts into functional neurons \[[@CR42]\]. BRN1, BRN2 and OCT6 mutants show defects in layering of the neocortex, due to their role in initiating radial migration of cortical projection neurons, further highlighting their role in promoting neurogenesis \[[@CR43]--[@CR45]\]. Furthermore, we find an enrichment of both octamers and E-boxes in REs promoting gene expression in the MGE, suggesting that the TF machinery directing trans-differentiation of fibroblasts into neurons is similar to the TF machinery inducing neuronal phenotypes in the MGE. Trans-differentiating fibroblast to neurons using Brn2, Ascl1 and Myt1l generate cells with a mixed neuronal phenotype \[[@CR42]\], indicating that these TFs are required for promoting the neuronal fate, without any preference for specific neuronal lineages. Taken together, this suggests a model where neuronal fate and phenotype is directed through separate, although integrated, TF pathways in the MGE.

One of the octamers in *hs623* is paired with a SOX motif. The SOX TF family consists of a large number of genes that direct embryonic development and cell differentiation. They bind loosely to the minor groove of the DNA and their target gene specificity is guided through the interaction with cell type specific partner factors such as OCT TFs. The combined activity of SOX2 and different OCT TFs are important regulators of gene expression in undifferentiated embryonic stem cells (ESCs) and neural progenitor cells (NPCs) \[[@CR46]\]. SOX2 and OCT4 (POU5F1) bind REs in ECSs, whereas SOX2 and BRN2 (POU3F2) co-occupy REs in NPCs \[[@CR34], [@CR46]--[@CR48]\]. SOX and OCT motifs have also been shown to direct transcription in both ESCs and NPCs in the forebrain \[[@CR34], [@CR35]\]. Today we do not know what specific OCT and SOX TFs that are required to activate transcription in the SVZ of the MGE, via REs like *hs623*, BRN1 (POU3F3), BRN2 (POU3F2), BRN4 (POU3F4), BRN5 (POU6F1) and OCT6 (POU3F1) are all expressed here, but little is know regarding their function in this context. A large number of different SOX TFs are expressed in the MGE and several of them show a reduced expression in the *Nkx2--1*cKO, such as Sox1, Sox2, Sox6, Sox11 and Sox21 constituting possible candidates for promoting *Tcf12* expression via *hs623*. Sox6 is required for patterning of the subpallium and generation on MGE derived interneurons \[[@CR49], [@CR50]\], but when looking at *Tcf12* expression in the E13.5 MGE of a conditional *Sox6* mouse \[[@CR51]\] with an *Nkx2--1*-Cre line \[[@CR52]\], we found no significant change in *Tcf12* expression (Additional file [4](#MOESM4){ref-type="media"}). From this we can suggest that SOX6 is not sufficient for promoting *Tcf12* expression. Further studies should be performed to identify the specific OCT and SOX TFs directing transcriptional activation in the MGE.

Here, in our new analysis of the *Nkx2--1c*KO, we found a large number aREs. Some of these are near the loci of the *Tcf4* and *Tcf12* bHLH TF encoding genes. The *Nkx2--1*cKO shows a near complete loss of *Tcf12* expression in the SVZ and MZ of the MGE. We found an aRE intronic to *Tcf12* (*hs623*) that has activity in the SVZ and MZ of the MGE (Fig. [2e](#Fig2){ref-type="fig"}). Deletion of *hs623* leads to a reduced *Tcf12* expression in the VZ and MZ of the MGE. This result suggests that *Tcf12* expression is regulated through several aREs, including *hs623*, and that there is redundancy between these REs. Enhancer redundancy has been demonstrated in the developing telencephalon and limb where REs sharing a similar spatiotemporal activity provides robustness to gene expression \[[@CR53], [@CR54]\]. We also find that there are different genetic programs directing *Tcf12* expression in various cell types of the MGE. *Tcf12* expression is initiated in the VZ of the MGE; this expression is largely unaffected in the *Nkx2--1*cKO, indicating that *Tcf12* expression in this region is not mediated through *hs623* and largely NKX2--1 independent.

Altogether, these data provide evidence of transcriptional circuitry that connects the initiation of MGE fate in the VZ by *Nkx2--1* and *Otx2*, to the maturation of cells in the SVZ and MZ by driven through REs such as *hs632,* whose activity integrates signals from LHX, OCT, SOX and bHLH TFs \[[@CR16], [@CR18], [@CR55]\]. Future studies will investigate how TFs, chromatin-binding, −reading and -remodeling proteins integrate to direct GABAergic and cholinergic development in the subpallial telencephalon.

Conclusion {#Sec21}
==========

In our study we use a combination of genomics, CRISPR/Cas9 engineering and TF motif analysis to investigate the transcriptional networks guiding development of the MGE and its descendants. Whereas NKX2--1 is required for initiating MGE characteristics in the VZ, we provide evidence that a combination of LHX, OCT, SOX and bHLH TFs are central for maintaining gene expression in the SVZ and MZ, genetically down-stream of NKX2--1. Here we generate a mouse mutant in whom we delete a *Tcf12* intragenic RE, showing its requirement for maintaining *Tcf12* transcription in the SVZ and MZ of the MGE. The activity of this *Tcf12* enhancer, in primary cultures of MGE cells, largely depends on an octamer and a combined octamer and SOX motif. Altogether, our study identifies a genomic framework through which a combination of LHX, OCT, SOX and bHLH TFs direct MGE differentiation through the expression terminal effector genes.
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